Abstract
Man, 54 years old, ex-smoker since 20 years (25 smoked cigarettes for 15 years), mildly overweight, and hypertensive since 10 years. He began to be pharmacologically treated with antihypertensive drugs from the age of 50: his doctor prescribed him hydrochlorothiazide 25 mg per day. Initially, he tried atenolol 50 mg, but he had to stop it because of perceived decrease in sexual performances. Three months ago he suffered from a gout attack that resolved in a couple of weeks. Then, he was treated with allopurinol 300 mg ½ tablet per day which was not very well tolerated because of gastrointestinal discomfort. Recently, he came to our hypertension clinic for a general checkup because his blood pressure seems to be totally out of control.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.
Borghi C. The role of uric acid in the development of cardiovascular disease. Curr Med Res Opin. 2015;31 Suppl 2:1–2.
Galassi FM, Borghi C. A brief history of uric acid: from gout to cardiovascular risk factor. Eur J Intern Med. 2015;26:373.
Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729–41.
MacIsaac RL, Salatski J, Higgins P, Walters MR, Padmanabjan S, Dominiczak AF, Touyz RM, Dawson J. Allopurinol and cardiovascular outcomes in adults with hypertension. Hypertension. 2016;67:535–40.
Borghi C, Desideri G. Urate-lowering drugs and prevention of cardiovascular disease: the emerging role of xanthine oxidase inhibition. Hypertension. 2016;67(3):496–8.
Cicero AF, Rosticci M, Tocci G, Bacchelli S, Urso R, D’Addato S, Borghi C. Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort. Eur J Intern Med. 2015;26(4):255–8.
Smink PA, Bakker SJ, Laverman GD, Berl T, Cooper ME, de Zeeuw D, LambersHeerspink HJ. An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials. J Hypertens. 2012;30(5):1022–8.
Altan A, Shiozawa A, Bancroft T, Singh JA. A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database. J Clin Rheumatol. 2015;21(8):411–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cicero, A.F.G. (2016). Clinical Case 6: Adult Patient with Hypertension and Gout. In: Hypertension and Metabolic Cardiovascular Risk Factors. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-39504-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-39504-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39503-6
Online ISBN: 978-3-319-39504-3
eBook Packages: MedicineMedicine (R0)